Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer [clinicaltrials:NCT00003520]
Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer [clinicaltrials:NCT00003520]
Bio2RDF identifier
NCT00003520
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00003520
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Antineoplast ...... have stage IV kidney cancer.
brief title [clinicaltrials_vocabulary:brief-title]
Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
- ...... ll be accrued for this study.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
metastatic transitional cell cancer of the renal pelvis and ureter
recurrent renal cell cancer
recurrent transitional cell cancer of the renal pelvis and ureter
stage IV renal cell cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2008-07-23T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00003520
official title [clinicaltrials_vocabulary:official-title]
Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Kidney
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000066564
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1998-08-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2004-04-01T00:00:00Z
identifier
clinicaltrials:NCT00003520
title
Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
@en
type
label
Antineoplaston Therapy in Trea ...... r [clinicaltrials:NCT00003520]
@en